The Secret Life of Exosomes: What Bees Can Teach Us About Next-Generation Therapeutics

Journal of the American College of Cardiology

Volumn 71, Issue 2, 2018, Pages 193-200

  Marbán, Eduardo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

cell therapy; exosomes; vesicle

Indexed keywords

MICRORNA; UNTRANSLATED RNA;

BONE MARROW DERIVED MONONUCLEAR CELL; CARDIAC MUSCLE CELL; CARDIOPOIETIC CELL; CARDIOSPHERE DERIVED CELL; CELL ACTIVITY; CELL ISOLATION; CELL THERAPY; CLINICAL EFFECTIVENESS; ENDOTHELIAL PROGENITOR CELL; EXOSOME; HEART FAILURE; HONEYBEE; HUMAN; MESENCHYMAL STEM CELL; NECTAR; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; BIOLOGICAL THERAPY; CELL COMMUNICATION; METABOLISM; PHYSIOLOGY; PROCEDURES;

CELL COMMUNICATION; CELL- AND TISSUE-BASED THERAPY; EXOSOMES; EXTRACELLULAR VESICLES; HEART FAILURE; HUMANS;

EID: 85040549195     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.11.013     Document Type: Review

References (60)

1. Clarivate Analytics. Journal Citation Reports. Available at: https://clarivate.com/products/journal-citation-reports/. Accessed November 21, 2017.
2. Ibrahim, A., Marban, E., Exosomes: fundamental biology and roles in cardiovascular physiology. Annu Rev Physiol 78 (2016), 67–83.
3. Dumas, M.E., Emanueli, C., Circulating microRNAs to predict the risk for metabolic diseases in the general population?. Diabetes 66 (2017), 565–567.
4. Hirshman, B.R., Kras, R.T., Akers, J.C., Carter, B.S., Chen, C.C., Extracellular vesicles in molecular diagnostics: an overview with a focus on CNS diseases. Adv Clin Chem 76 (2016), 37–53.
5. Ni, H., Xu, J., Recent trends in heart failure-related mortality: United States, 2000–2014. NCHS Data Brief, 2015, 1–8.
6. Roth, G.A., Johnson, C., Abajobir, A., et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70 (2017), 1–25.
7. Marinescu, K.K., Uriel, N., Mann, D.L., Burkhoff, D., Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery. Expert Rev Med Devices 14 (2017), 15–26.
8. Gallet, R., de Couto, G., Simsolo, E., et al. Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation. J Am Coll Cardiol Basic Trans Science 1 (2016), 14–28.
9. Sanganalmath, S.K., Bolli, R., Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113 (2013), 810–834.
10. Gerbin, K.A., Murry, C.E., The winding road to regenerating the human heart. Cardiovasc Pathol 24 (2015), 133–140.
11. Menasche, P., Vanneaux, V., Stem cells for the treatment of heart failure. Curr Res Transl Med 64 (2016), 97–106.
12. ClinicalTrials.gov. Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure (DREAM HF-1). Available at: https://clinicaltrials.gov/ct2/show/NCT02032004. Accessed November 21, 2017.
13. ClinicalTrials.gov. HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) (HOPE). Available at: https://clinicaltrials.gov/ct2/show/NCT02485938. Accessed November 21, 2017.
14. Chimenti, I., Smith, R.R., Li, T.S., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106 (2010), 971–980.
15. Malliaras, K., Li, T.S., Luthringer, D., et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 125 (2012), 100–112.
16. Marzesco, A.M., Janich, P., Wilsch-Brauninger, M., et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 118 (2005), 2849–2858.
17. Lai, R.C., Arslan, F., Lee, M.M., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4 (2010), 214–222.
18. Sahoo, S., Klychko, E., Thorne, T., et al. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res 109 (2011), 724–728.
19. Ibrahim, A.G., Cheng, K., Marban, E., Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports 2 (2014), 606–619.
20. Chen, B., Li, Q., Zhao, B., Wang, Y., Stem cell-derived extracellular vesicles as a novel potential therapeutic tool for tissue repair. Stem Cells Transl Med 6 (2017), 1753–1758.
21. Wang, Y., Zhang, L., Li, Y., et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol 192 (2015), 61–69.
22. Kervadec, A., Bellamy, V., El Harane, N., et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J Heart Lung Transplant 35 (2016), 795–807.
23. Khan, M., Nickoloff, E., Abramova, T., et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res 117 (2015), 52–64.
24. Caporali, A., Meloni, M., Nailor, A., et al. p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia. Nat Commun, 6, 2015, 8024.
25. Wang, X., Gu, H., Qin, D., et al. Exosomal miR-223 contributes to mesenchymal stem cell-elicited cardioprotection in polymicrobial sepsis. Sci Rep, 5, 2015, 13721.
26. Cambier, L., de Couto, G., Ibrahim, A., et al. Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion. EMBO Mol Med 9 (2017), 337–352.
27. Gomes, C.P.C., Spencer, H., Ford, K.L., et al. The function and therapeutic potential of long non-coding RNAs in cardiovascular development and disease. Mol Ther Nucleic Acids 8 (2017), 494–507.
28. Zwetsloot, P.P., Vegh, A.M., Jansen of Lorkeers, S.J., et al. Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ Res 118 (2016), 1223–1232.
29. Nigro, P., Bassetti, B., Cavallotti, L., Catto, V., Carbucicchio, C., Pompilio, G., Cell therapy for heart disease after 15 years: unmet expectations. Pharmacol Res, 2017 Feb 21 [E-pub ahead of print].
30. Dodson, B.P., Levine, A.D., Challenges in the translation and commercialization of cell therapies. BMC Biotechnol, 15, 2015, 70.
31. Akers, J.C., Ramakrishnan, V., Yang, I., et al. Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid. Cancer Biomark 17 (2016), 125–132.
32. Aminzadeh MA, Rogers RG, Gouin K, et al. Reversal of cardiac and skeletal manifestations of Duchenne muscular dystrophy by cardiosphere-derived cells and their exosomes in mdx dystrophic mice and in human Duchenne cardiomyocytes. bioRxiv. Available at: https://www.biorxiv.org/content/early/2017/04/20/128900. Accessed November 21, 2017.
33. de Couto, G., Gallet, R., Cambier, L., et al. Exosomal microRNA transfer into macrophages mediates cellular postconditioning. Circulation 136 (2017), 200–214.
34. Gallet, R., Dawkins, J., Valle, J., et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J 38 (2017), 201–211.
35. Chen, K.H., Chen, C.H., Wallace, C.G., et al. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. Oncotarget 7 (2016), 74537–74556.
36. Vandergriff, A.C., de Andrade, J.B., Tang, J., et al. Intravenous cardiac stem cell-derived exosomes ameliorate cardiac dysfunction in doxorubicin induced dilated cardiomyopathy. Stem Cells Int, 2015, 2015, 960926.
37. Conlan, R.S., Pisano, S., Oliveira, M.I., Ferrari, M., Mendes Pinto, I., Exosomes as reconfigurable therapeutic systems. Trends Mol Med 23 (2017), 636–650.
38. van der Pol, E., Boing, A.N., Harrison, P., Sturk, A., Nieuwland, R., Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64 (2012), 676–705.
39. Besse, B., Charrier, M., Lapierre, V., et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology, 5, 2016, e1071008.
40. Kordelas, L., Rebmann, V., Ludwig, A.K., et al. MSC–derived exosomes: a novel tool to treat therapy–refractory graft-versus-host disease. Leukemia 28 (2014), 970–973.
41. ClinicalTrials.gov. Effect of Plasma Derived Exosomes on Intractable Cutaneous Wound Healing: Prospective Trial. Available at: https://clinicaltrials.gov/ct2/show/NCT02565264. Accessed November 21, 2017.
42. Tang, Y.T., Huang, Y.Y., Zheng, L., et al. Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum. Int J Mol Med 40 (2017), 834–844.
43. Lotvall, J., Hill, A.F., Hochberg, F., et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles, 3, 2014, 26913.
44. Liu, F., Gao, J., Di, N., Adler, L.S., Nectar attracts foraging honey bees with components of their queen pheromones. J Chem Ecol 41 (2015), 1028–1036.
45. Riddle S. The chemistry of honey. Bee Culture: the Magazine of American Beekeeping; July 25, 2016. Available at: http://digital.beeculture.com/. Accessed November 15, 2017.
46. Luan, X., Sansanaphongpricha, K., Myers, I., Chen, H., Yuan, H., Sun, D., Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38 (2017), 754–763.
47. Armstrong, J.P., Holme, M.N., Stevens, M.M., Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano 11 (2017), 69–83.
48. Peche, H., Heslan, M., Usal, C., Amigorena, S., Cuturi, M.C., Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76 (2003), 1503–1510.
49. Hawari, F.I., Rouhani, F.N., Cui, X., et al. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc Natl Acad Sci U S A 101 (2004), 1297–1302.
50. Gupta, S., Knowlton, A.A., HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 292 (2007), H3052–H3056.
51. Azevedo, L.C., Janiszewski, M., Pontieri, V., et al. Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Crit Care, 11, 2007, R120.
52. Vrijsen, K.R., Sluijter, J.P., Schuchardt, M.W., et al. Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med 14 (2010), 1064–1070.
53. Hergenreider, E., Heydt, S., Treguer, K., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14 (2012), 249–256.
54. Lee, C., Mitsialis, S.A., Aslam, M., et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126 (2012), 2601–2611.
55. Ismail, N., Wang, Y., Dakhlallah, D., et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 121 (2013), 984–995.
56. Barile, L., Gherghiceanu, M., Popescu, L.M., Moccetti, T., Vassalli, G., Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres. J Biomed Biotechnol, 2012, 2012, 354605.
57. Bang, C., Batkai, S., Dangwal, S., et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124 (2014), 2136–2146.
58. Gray, W.D., French, K.M., Ghosh-Choudhary, S., et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res 116 (2015), 255–263.
59. Kapustin, A.N., Chatrou, M.L., Drozdov, I., et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 116 (2015), 1312–1323.
60. Pironti, G., Strachan, R.T., Abraham, D., et al. Circulating exosomes induced by cardiac pressure overload contain functional angiotensin II type 1 receptors. Circulation 131 (2015), 2120–2130.